Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection
Author:
Publisher
Springer Science and Business Media LLC
Subject
Virology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00705-013-1807-3.pdf
Reference55 articles.
1. Webster RG, Wright SM, Castrucci MR, Bean WJ, Kawaoka Y (1993) Influenza–a model of an emerging virus disease. Intervirology 35(1–4):16–25
2. Webby RJ, Webster RG (2003) Are we ready for pandemic influenza? Science 302:1519–1522
3. Morse SS, Mazet JA, Daszak P et al (2012) Prediction and prevention of the next pandemic zoonosis. Lancet 380:1956–1965
4. Garten RJ, Davis CT, Cox NJ et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325(5937):197–201
5. Cheng VC, To KK, Tse H, Hung IF, Yuen KY (2012) Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 25(2):223–263
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngeneic mouse model;Frontiers in Pharmacology;2023-05-18
2. In vitro and in vivo antiviral effect of Fufang Yinhua Jiedu granules (FFYH) combined with oseltamivir against influenza A virus;Phytomedicine Plus;2023-02
3. Animal models of disease states;Basic Principles of Drug Discovery and Development;2021
4. Basic pharmacological mechanisms and clinical evidence of the efficacy of hochuekkito against infectious diseases and its potential for use against COVID‐19;Traditional & Kampo Medicine;2020-12-02
5. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease;Biomedicine & Pharmacotherapy;2020-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3